FWM
GSK icon

Foresight Wealth Management’s GSK GSK Stock Holding History

Foresight Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-22,077
Closed -$650K – 45
2022
Q3 		$650K Buy
22,077
+2,229
+11% +$84.5K 0.15% 61
2022
Q2 		$1.08M Buy
19,848
+1,332
+7% +$73.5K 0.22% 37
2022
Q1 		$1.01M Buy
18,516
+3,688
+25% +$200K 0.19% 45
2021
Q4 		$817K Buy
14,828
+641
+5% +$33.3K 0.01% 56
2021
Q3 		$678K Sell
14,187
-521
-4% -$26.2K 0.14% 56
2021
Q2 		$732K Buy
14,708
+2,441
+20% +$117K 0.16% 62
2021
Q1 		$547K Buy
12,267
+4,883
+66% +$222K 0.14% 69
2020
Q4 		$340K Buy
+7,384
New +$339K 0.09% 90

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Foresight Wealth Management's GSK Position: Q4 2022 in Review

Foresight Wealth Management sold out of GSK (GSK) in Q4 2022, closing a stake of 22,077 shares — an estimated $650K sold.

Foresight Wealth Management first reported a position in GSK in Q4 2020 and held it in 8 quarters. The position peaked at $1.08M in Q2 2022. 813 funds tracked by Wall St. Rank hold GSK as of Q4 2022.

  • Foresight Wealth Management reported no remaining GSK position as of Q4 2022 after selling out during the quarter.
  • Foresight Wealth Management sold 22,077 GSK shares in Q4 2022, an estimated $650K.
  • Foresight Wealth Management first reported a position in GSK in Q4 2020 and held it in 8 quarters.
  • Foresight Wealth Management's GSK position peaked at $1.08M in Q2 2022.
  • 813 funds tracked by Wall St. Rank held GSK as of Q4 2022.

Based on Foresight Wealth Management's 13F filing for Q4 2022, filed 13 Feb 2023.